FDA Guidance for Industry: Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis C Virus (HCV): Testing, Product Disposition, and Donor Deferral and Reentry
Titel:
FDA Guidance for Industry: Nucleic Acid Testing (NAT) for
Human Immunodeficiency Virus Type 1 (HIV-1) and
Hepatitis C Virus (HCV): Testing, Product Disposition, and
Donor Deferral and Reentry
Internet:
Herkunft/Verlag:
Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/ , http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM210270.pdf
Dokumentenart:
Guidance for Industry
Inhalt:
Empfehlungen für Blutspendeeinrichtuneg, Labore und Verarbeiter bei der Einführung von lizensieten Methoden auf Nukeinsärenbasis zur HIV unf HCV Testung